Raymond James Starts Karyopharm Therapeutics (KPTI) at Outperform
Get Alerts KPTI Hot Sheet
Price: $1.51 +2.03%
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
12 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Raymond James initiated coverage on Karyopharm Therapeutics (NASDAQ: KPTI) with an Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Karyopharm Therapeutics click here. For more ratings news on Karyopharm Therapeutics click here.
Shares of Karyopharm Therapeutics closed at $9.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Resumes GoDaddy Inc (GDDY) at Strong Buy
- Piper Sandler Starts SI-BONE Inc. (SIBN) at Overweight, 'would recommend investors own the name'
- Raymond James Resumes LegalZoom.com Inc (LZ) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!